BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16102886)

  • 1. A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome.
    Walch K; Grimm C; Huber JC; Nagele F; Kolbus A; Hefler LA
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):77-81. PubMed ID: 16102886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
    Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
    Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.
    Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY
    J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis.
    Chen YL; Zhang JX; Wang PX; Cui RZ; Zhao FM; Mao YM; Li JY; Bi YY; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):624-7. PubMed ID: 16331557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
    Sun L; Lv H; Wei W; Zhang D; Guan Y
    J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome.
    Sales MF; Sóter MO; Candido AL; Fernandes AP; Oliveira FR; Ferreira AC; Sousa MO; Ferreira CN; Gomes KB
    Gynecol Endocrinol; 2013 Oct; 29(10):936-9. PubMed ID: 23898913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome].
    Zhao JL; Chen ZJ; Zhao YR; Zhao LX; Wang LC; Tang R; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):528-31. PubMed ID: 16202290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with polycystic ovary syndrome in Chinese patients: a meta-analysis.
    Wang LH; Wang LM; Zhou N
    Arch Gynecol Obstet; 2015 Sep; 292(3):683-6. PubMed ID: 25731152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
    Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
    Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population.
    Song X; Ge L; Wang D; Li L; Ma D; Li X; Song X
    J Obstet Gynaecol; 2022 Oct; 42(7):3304-3308. PubMed ID: 36065507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia.
    Häkli T; Romppanen EL; Hiltunen M; Helisalmi S; Punnonen K; Heinonen S
    Genet Test; 2003; 7(3):265-8. PubMed ID: 14642005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reproductive problems in women with PCOS, the impact of PAL-1 CARRIERS OF 4G PAI -1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Slavov N; Popovski K; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(5):3-9. PubMed ID: 25558663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
    Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
    J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reproductive problems in women with PCOS, the impact of PAI-1 carriers of 4G PAI-1 polymorphism and BMI].
    Komsa-Penkova R; Golemanov G; Georgieva G; Popovski K; Slavov N; Ivanov P; Kovacheva K; Atanasova M; Blajev A
    Akush Ginekol (Sofiia); 2014; 53(6):15-21. PubMed ID: 25672133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
    Bagos PG
    Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
    Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
    Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Bae SC; Lee YH
    Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.